Your Path :: Home > LASIK > LASIK Fundamentals > Other Refractive Surgeries > Other Surgeries

Automated Lamellar Keratoplasty (ALK)


In ALK, the surgeon uses the microkeratome to separate a layer of the cornea and create a flap. The flap is then folded back, and the microkeratome removes a thin disc of corneal stroma below. The thickness and diameter of this disc determines the change in refractive error. The surgeon then places the flap back into position. This procedure can correct large amounts of myopia and hyperopia. However, the resultant change is not as predictable as with other procedures.

Conductive Keratoplasty


Used to treat hyperopia, CK steepens the central cornea by using radio frequency energy to shrink the collagen in peripheral cornea. With CK, the surgeon uses a radio frequency probe rather than a laser to apply the heat. One published multi-center study reports 12-month data on 203 eyes and notes that 51% had uncorrected visual acuity of 20/20 or better at that point.1 The device used in the technique received FDA approval in April 2002. According to the Reuters 2, the procedure takes approximately 3 minutes and can be performed in the surgeon's office. Patients may experience visual fluctuations for the first couple of weeks following the surgery. The report states that studies have demonstrated the effects last for at least two years. One percent of patients developed induced astigmatism as a complication of the procedure. Patients interested in this option should discuss it with their ophthalmologist.


Micro-thin Prescription Inserts


Micro-thin Prescription Inserts INTACS™ are two small arcs of medical plastic that a surgeon places into the mid-periphery of the corneal stroma. Once in place, the inserts cause a slight stretching of the cornea and a subtle flattening of the corneal curvature. The change in curvature varies with the thickness of the inserts. To place the inserts, the surgeon must first create a small incision in the periphery of the cornea. The inserts are then placed. Finally, the surgeon closes the incision (a suture may sometimes be required). Once placed, the inserts can be removed or replaced by the surgeon if the patient's vision needs change. Under U.S. clinical study since 1991, KeraVision INTACS™ received FDA approval for the correction of -1.00 to -3.00 D of myopia with no more than 1.00 D of astigmatism in April 1999.

Multiple Procedures


Doctors will sometimes use two or more procedures to treat patients suffering from high to severe myopia. For instance, ophthalmologists have inserted phakic IOLs and then performed LASIK to achieve the desired refraction in eyes with more than -15D of myopia pre-operatively. Surgeons have also performed initial LASIK procedures then inserted ICRS to correct residual errors.
However, patients should understand that the use of multiple procedures is a relatively new option in many countries, including the United States. Very little study data has been accumulated on the long-term effects of multiple procedures, and patients may need to look harder to find a surgeon currently performing such procedures in combination with one another.

RK


Radial keratotomy, or RK, was refined by a Russian ophthalmologist in 1963 and involves using a diamond scalpel blade to make usually four to eight tiny spoke-like incisions in the periphery of cornea. The incisions slightly weaken the peripheral cornea, causing it to bulge. This flattens the center of the cornea, thus reducing myopia.
RK has its drawbacks. The resulting change in refractive error is felt to be less predictable because no one can control the way the incisions heal. As a result, RK may only reduce myopia, not completely eliminate it. RK patients may still need to wear glasses for distance. In addition, with time, RK can result in overcorrection.
Because of advances in laser technology, surgeons perform RK only on a select group of patients.


1. Asbell PA, Maloney RK, Davidorf J, Hersh P, McDonald M, Manche E, Conductive Keratoplasty Study Group. Conductive keratoplasty for the correction of hyperopia. Trans Am Ophthalmol Soc 2001;99:79-84
2. FDA Approves Farsightedness Treatment" Reuters Tues April 16, 2002 5:19 ET accessed from here


Contact Us

  Home | Glossary | Find A Surgeon
  ESEC Information | ESEC News | LASIK Screening Guidelines

The content provided within this website is for informational purposes only. It should not be used as a substitute for professional medical advice. The information is provided without warranty of any kind, expressed or implied, and use of the information is strictly voluntary at user's sole risk.
© Copyright 2003 ASCRS


Designed by: http://www.mojointeractive.com